26 Corporate Circle
Albany, New York, 12203
AMRI's business segments include Discovery and Development Services (DDS), Active Pharmaceutical Ingredients (API) and Drug Product Manufacturing. DDS provides expertise with diverse chemistry, library design and synthesis, in vitro biology and pharmacology, drug metabolism and pharmacokinetics, and natural products. Our API segment supports the chemical development and cGMP manufacture of complex API, including potent/cytotoxic and controlled substances, biologics, peptides and steroids. Drug Product supports pre-clinical through commercial-scale production of complex liquid-filled and lyophilized parenteral formulations.
With the first DSCSA serialization deadline just two years away, how should contract manufacturers and packagers begin to pla